Evidence map›Paper›PMID 33353006›Full record

ArticleSensors (Basel, Switzerland)2020

Direct and Label-Free Determination of Human Glycated Hemoglobin Levels Using Bacteriorhodopsin as the Biosensor Transducer.

Ying-Chin Lin, Ching-Yu Lin, Hsiu-Mei Chen, Li-Pin Kuo, Cheng-En Hsieh, Xiang-He Wang, Chih-Wen Cheng, Chih-Yin Wu, Yi-Su Chen

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ying-Chin LinDepartment of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Ching-Yu LinSchool of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0001-8269-797X
Hsiu-Mei ChenDepartment of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 10607, Taiwan.
Li-Pin KuoDepartment of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 10607, Taiwan.
Cheng-En HsiehDepartment of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 10607, Taiwan.
Xiang-He WangDepartment of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 10607, Taiwan.
Chih-Wen ChengDepartment of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 10607, Taiwan.
Chih-Yin WuDepartment of Family Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan.ORCID 0000-0001-6002-3608
Yi-Su ChenDepartment of Family Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan.
National Taiwan University of Science and Technology · TWWan Fang Hospital · TWTaipei Medical University · TW

Funding

Ministry of Science and Technology (MOST), Taiwan MOST 107-2221-E-011-069-MY2
6 · The paper itself

Abstract

Glycated hemoglobin (HbA1c) levels are an important index for the diagnosis and long-term control of diabetes. This study is the first to use a direct and label-free photoelectric biosensor to determine HbA1c using bacteriorhodopsin-embedded purple membranes (PM) as a transducer. A biotinylated PM (b-PM) coated electrode that is layered with protein A-oriented antibodies against hemoglobin (Hb) readily captures non-glycated Hb (HbA0) and generates less photocurrent. The spectra of bacteriorhodopsin and Hb overlap so the photocurrent is reduced because of the partial absorption of the incident light by the captured Hb molecules. Two HbA0 and HbA1c aptasensors that are prepared by conjugating specific aptamers on b-PM coated electrodes single-step detect HbA0 and HbA1c in 15 min, without cross reactivity, with detection limits of ≤0.1 μg/mL and a dynamic range of 0.1-100 μg/mL. Both aptasensors exhibit high selectivity and long-term stability. For the clinical samples, HbA0 concentrations and HbA1c levels that are measured with aptasensors correlate well with total Hb concentrations and the HbA1c levels that are determined using standard methods (correlation gradient = 0.915 ± 0.004 and 0.981 ± 0.001, respectively). The use of these aptasensors for diabetes care is demonstrated.

Indexed as

BacteriorhodopsinsBiosensing TechniquesAnimalsGlycated HemoglobinHumansRabbitsTransducersBacteriorhodopsinsGlycated Hemoglobinbacteriorhodopsinglycated hemoglobinphotoelectric biosensorpurple membrane

Identifiers

PMID33353006
PMCPMC7765918
OpenAlexW3113112687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.